ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis
NASDAQ:ICHR - Nasdaq - KYG4740B1059 - Common Stock - Currency: USD
Overall ICHR gets a fundamental rating of 4 out of 10. We evaluated ICHR against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of ICHR is average, but there are quite some concerns on its profitability. ICHR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ICHR had positive earnings in the past year.
In the past year ICHR had a positive cash flow from operations.
In multiple years ICHR reported negative net income over the last 5 years.
ICHR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ICHR's Return On Assets of -1.63% is on the low side compared to the rest of the industry. ICHR is outperformed by 61.82% of its industry peers.
ICHR has a Return On Equity of -2.34%. This is in the lower half of the industry: ICHR underperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.63% | ||
| ROE | -2.34% | ||
| ROIC | N/A |
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ICHR has a Gross Margin of 12.20%. This is amonst the worse of the industry: ICHR underperforms 89.09% of its industry peers.
ICHR's Gross Margin has declined in the last couple of years.
ICHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 12.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
2. Health
2.1 Basic Checks
ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ICHR has more shares outstanding
The number of shares outstanding for ICHR has been increased compared to 5 years ago.
Compared to 1 year ago, ICHR has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.08 indicates that ICHR is not in any danger for bankruptcy at the moment.
ICHR has a Altman-Z score of 3.08. This is comparable to the rest of the industry: ICHR outperforms 46.36% of its industry peers.
ICHR has a debt to FCF ratio of 12.16. This is a negative value and a sign of low solvency as ICHR would need 12.16 years to pay back of all of its debts.
ICHR has a Debt to FCF ratio (12.16) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.17 indicates that ICHR is not too dependend on debt financing.
ICHR has a Debt to Equity ratio of 0.17. This is comparable to the rest of the industry: ICHR outperforms 49.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 12.16 | ||
| Altman-Z | 3.08 |
ROIC/WACCN/A
WACC11.4%
2.3 Liquidity
A Current Ratio of 3.09 indicates that ICHR has no problem at all paying its short term obligations.
ICHR's Current ratio of 3.09 is in line compared to the rest of the industry. ICHR outperforms 51.82% of its industry peers.
A Quick Ratio of 1.32 indicates that ICHR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.32, ICHR is doing worse than 79.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.09 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
ICHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 716.67%, which is quite impressive.
The earnings per share for ICHR have been decreasing by -33.82% on average. This is quite bad
ICHR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.41%.
ICHR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.46% yearly.
EPS 1Y (TTM)716.67%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%233.33%
Revenue 1Y (TTM)13.41%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%21.39%
3.2 Future
ICHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 78.84% yearly.
The Revenue is expected to grow by 9.45% on average over the next years. This is quite good.
EPS Next Y388.41%
EPS Next 2Y206.76%
EPS Next 3Y123.87%
EPS Next 5Y78.84%
Revenue Next Year12.02%
Revenue Next 2Y9.31%
Revenue Next 3Y8.16%
Revenue Next 5Y9.45%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 64.19, which means the current valuation is very expensive for ICHR.
ICHR's Price/Earnings is on the same level as the industry average.
ICHR is valuated expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 15.77, ICHR is valued correctly.
83.64% of the companies in the same industry are more expensive than ICHR, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, ICHR is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.19 | ||
| Fwd PE | 15.77 |
4.2 Price Multiples
ICHR's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as ICHR.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 77.72 | ||
| EV/EBITDA | 31.63 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ICHR's earnings are expected to grow with 123.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.17
PEG (5Y)N/A
EPS Next 2Y206.76%
EPS Next 3Y123.87%
5. Dividend
5.1 Amount
ICHR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.75
+0.04 (+0.17%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners98.51%
Inst Owner Change0.01%
Ins Owners2.07%
Ins Owner Change15.9%
Market Cap810.35M
Analysts80
Price Target29.75 (25.26%)
Short Float %3.14%
Short Ratio2.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.26%
Min EPS beat(2)-55.02%
Max EPS beat(2)-9.51%
EPS beat(4)2
Avg EPS beat(4)2.24%
Min EPS beat(4)-55.02%
Max EPS beat(4)63.4%
EPS beat(8)3
Avg EPS beat(8)-551.18%
EPS beat(12)6
Avg EPS beat(12)-361.29%
EPS beat(16)7
Avg EPS beat(16)-272.8%
Revenue beat(2)0
Avg Revenue beat(2)-1.95%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)-1.73%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.07%
Revenue beat(12)7
Avg Revenue beat(12)0.24%
Revenue beat(16)7
Avg Revenue beat(16)-0.59%
PT rev (1m)0%
PT rev (3m)-31.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-56.54%
EPS NY rev (1m)0%
EPS NY rev (3m)-44.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.19 | ||
| Fwd PE | 15.77 | ||
| P/S | 0.91 | ||
| P/FCF | 77.72 | ||
| P/OCF | 19.27 | ||
| P/B | 1.16 | ||
| P/tB | 2.55 | ||
| EV/EBITDA | 31.63 |
EPS(TTM)0.37
EY1.56%
EPS(NY)1.51
Fwd EY6.34%
FCF(TTM)0.31
FCFY1.29%
OCF(TTM)1.23
OCFY5.19%
SpS26.15
BVpS20.53
TBVpS9.33
PEG (NY)0.17
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.63% | ||
| ROE | -2.34% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 12.2% | ||
| FCFM | 1.17% |
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 12.16 | ||
| Debt/EBITDA | 4.56 | ||
| Cap/Depr | 101.22% | ||
| Cap/Sales | 3.55% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 160.66% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.09 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z | 3.08 |
F-Score6
WACC11.4%
ROIC/WACCN/A
Cap/Depr(3y)62.01%
Cap/Depr(5y)61.74%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)716.67%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%233.33%
EPS Next Y388.41%
EPS Next 2Y206.76%
EPS Next 3Y123.87%
EPS Next 5Y78.84%
Revenue 1Y (TTM)13.41%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%21.39%
Revenue Next Year12.02%
Revenue Next 2Y9.31%
Revenue Next 3Y8.16%
Revenue Next 5Y9.45%
EBIT growth 1Y73.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year258.23%
EBIT Next 3Y70.83%
EBIT Next 5Y52.36%
FCF growth 1Y-56.61%
FCF growth 3YN/A
FCF growth 5Y-22.51%
OCF growth 1Y-26.04%
OCF growth 3Y22.22%
OCF growth 5Y-13.37%